Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

IOVA

Iovance Biotherapeutics Inc

May 08 • 04:00PM ET

3.62

+0.07 1.97 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: LYEL ALLO AUTL SANA BEAM

| Held by: VTI XBI IWM VB VXF IWN VBR IBB VTWO SCHA

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.95	Insider Own	14.21%	Shs Outstand	438.11M	Perf Week	6.47%
Market Cap	1.62B	Forward P/E	-	EPS next Y	-0.28	Insider Trans	0.00%	Shs Float	383.04M	Perf Month	-9.73%
Enterprise Value	1.34B	PEG	-	EPS next Q	-0.13	Inst Own	53.99%	Short Float	28.41%	Perf Quarter	43.08%
Income	-353.86M	P/S	5.66	EPS this Y	50.45%	Inst Trans	12.68%	Short Ratio	6.58	Perf Half Y	100.00%
Sales	285.55M	P/B	2.20	EPS next Y	47.64%	ROA	-37.40%	Short Interest	108.80M	Perf YTD	32.60%
Book/sh	1.65	P/C	5.06	EPS next 5Y	-	ROE	-47.51%	52W High	5.63 -35.70%	Perf Year	14.20%
Cash/sh	0.72	P/FCF	-	EPS past 3/5Y	23.93% 10.23%	ROIC	-46.22%	52W Low	1.64 120.93%	Perf 3Y	-48.87%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	25.04%	Volatility	10.01% 7.64%	Perf 5Y	-87.31%
Dividend TTM	-	EV/Sales	4.71	EPS Y/Y TTM	23.00%	Oper. Margin	-125.41%	ATR (14)	0.28	Perf 10Y	-30.52%
Dividend Ex-Date	-	Quick Ratio	3.15	Sales Y/Y TTM	34.26%	Profit Margin	-123.92%	RSI (14)	49.68	Recom	1.64
Dividend Gr. 3/5Y	- -	Current Ratio	3.60	EPS Q/Q	47.50%	SMA20	-0.11%	Beta	0.68	Target Price	8.80
Payout	-	Debt/Eq	0.07	Sales Q/Q	44.82%	SMA50	-4.88%	Rel Volume	1.25	Prev Close	3.55
Employees	975	LT Debt/Eq	0.06	Earnings	May 07 BMO	SMA200	30.08%	Avg Volume	16.54M	Price	3.62
IPO	Sep 01, 2009	Option/Short	Yes / Yes	EPS/Sales Surpr.	-23.70% -8.23%	Trades		Volume	20,658,480	Change	1.97%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)